989 resultados para B ... n C ... f.


Relevância:

100.00% 100.00%

Publicador:

Resumo:

Background and aims: The prevalence of anti-HCV and HBsAg in Portugal has been shown to be elevated in high-risk groups, such as intravenous drug-users and incarcerated individuals. However, in the general population, prevalence remains largely unknown. The aims of this study were to estimate the prevalence of anti-HCV and HBsAg in the general Portuguese population and identify associated risk factors. Materials and methods: We carried out a nationwide, population-based cross-sectional study of adults resident in mainland Portugal. Serology for HBsAg, anti-HBc, anti-HBs, and anti-HCV was performed. Anti-HCV-positive individuals were tested for HCV RNA by PCR. Results: Of 1685 participants, 50.6% were men, mean age 50.2±18.3 years. In terms of hepatitis C, the prevalence of anti-HCV was 0.54% [95% confidence interval (CI): 0.2–0.9] and 0.12% (95% CI: 0.0–0.3) were viremic, with peak prevalence among individuals 35–64 years of age (0.8%), men (0.8%), and individuals from Lisbon and Tagus Valley region (1.9%). In terms of hepatitis B, the estimated prevalence of HBsAg was 1.45% (95% CI: 0.9–2.0). A higher prevalence was found in individuals who were 35–64 years old (2.2%), in men (2.5%), and in the Northern region (2.6%). The presence of positive serological markers of hepatitis C virus and hepatitis B virus infection did not correlate with elevated aminotransferases, race, place of birth, and alcohol consumption. Conclusion: These results suggest a low endemicity for both hepatitis B and hepatitis C in the general population, in contrast to a very high prevalence in risk groups, thus suggesting that targeted screening to high-risk groups may be more cost-effective than general population screening.

Relevância:

100.00% 100.00%

Publicador:

Resumo:

Resposta sistematizada para pergunta feita por agente comunitário de saúde, originada de teleconsultoria, sobre formas de transmissão, sinais e sintomas das hepatites virais A, B e C. Traz informações sobre os agentes causadores das hepatites virais, doenças que têm em comum o fato de infectarem as células do fígado, mas que apresentam características epidemiológicas, clínicas e laboratoriais distintas. Explica como ocorre a transmissão dos vírus e fornece detalhes sobre as manifestações clínicas dos três tipos de hepatite.

Relevância:

100.00% 100.00%

Publicador:

Resumo:

Apresentação e discussão do tema: Teste¡pidos HIV, Sífilis e Hepatites virais por Claudean Serra, seguido de debate.

Relevância:

80.00% 80.00%

Publicador:

Resumo:

Angular distributions for the elastic scattering of (8)B, (7)Be, and (6)Li on a (12)C target have been measured at E(lab) = 25.8, 18.8, and 12.3 MeV, respectively. The analyses of these angular distributions have been performed in terms of the optical model using Woods-Saxon and double-folding type potentials. The effect of breakup in the elastic scattering of (8)B + (12)C is investigated by performing coupled-channels calculations with the continuum discretized coupled-channel method and cluster-model folding potentials. Total reaction cross sections were deduced from the elastic-scattering analysis and compared with published data on elastic scattering of other weakly and tightly bound projectiles on (12)C, as a function of energy. With the exception of (4)He and (16)O, the data can be described using a universal function for the reduced cross sections.

Relevância:

80.00% 80.00%

Publicador:

Resumo:

Effects of titanium carbide (TiC) addition on structural and magnetic properties of isotropic (Pr,Nd)-Fe-B nanocrystalline magnetic materials have been investigated. In this work, we investigate the effect of TiC addition on a (Pr,Nd)-poor and B-rich composition, as well as on a B-poor and (Nd, Pr)-rich composition. Rapidly solidified (Pr, Nd)-Fe-B alloys were prepared by melt-spinning. The compositions studied were (Pr(1-x)Nd(x))(4)Fe(78)B(18) (x = 0, 0.5, and 1) with addition of 3 at% TiC. Unlike the (Pr(x)Nd(1-x))(9.5)Fe(84.5)B(6) materials that present excellent values for coercive. field and energy product, the (Pr,Nd)-poor and B-rich composition alloys with TiC addition present lower values. Rietveld analysis of X-ray data and Mossbauer spectroscopy revealed that samples are predominantly composed of Fe(3)B and alpha-Fe. For the RE-rich compositions (Pr(x)Nd(1-x))(9.5)Fe(84.5)B(6) (x = 0.1, 0.25, 0.5, 0.75, and 1) with the addition of 3 at% TiC, the highest coercive field and energy product (8.4 kOe and 14.4 MGOe, respectively) were obtained for the composition Pr(9.5)Fe(84.5)B(6). (c) 2008 Elsevier B.V. All rights reserved.

Relevância:

80.00% 80.00%

Publicador:

Resumo:

Background: Although most HIV-1 infections in Brazil are due to subtype B, Southern Brazil has a high prevalence of subtype C and recombinant forms, such as CRF31_BC. This study assessed the impact of viral diversity on clinical progression in a cohort of newly diagnosed HIV-positive patients. Methods: From July/2004 to December/2005, 135 HIV-infected patients were recruited. The partial pol region was subtyped by phylogeny. A generalized estimating equation (GEE) model was used to examine the relationship between viral subtype, CD4+ T cell count and viral load levels before antiretroviral therapy. Hazard ratio (Cox regression) was used to evaluate factors associated with viral suppression (viral load < 50 copies/mL at six months). Results: Main HIV-1 subtypes included B (29.4%), C (28.2%), and CRF31_BC (23.5%). Subtypes B and C showed a similar trend in CD4+ T cell decline. Comparison of non-B (C and CRF31_BC) and B subtypes revealed no significant difference in the proportion of patients with viral suppression at six months (week 24). Higher CD4+ T cell count and lower viral load were independently associated with viral suppression. Conclusion: No significant differences were found between subtypes; however, lower viral load and higher CD4+ T cell count before therapy were associated with better response.

Relevância:

80.00% 80.00%

Publicador:

Resumo:

Comorbidities in human immunodeficiency virus infection are of great interest due to their association with unfavorable outcomes and failure of antiretroviral therapy. This study evaluated the prevalence of coinfection by human immunodeficiency virus and viral hepatitis in an endemic area for hepatitis B in the Western Amazon basin. Serological markers for hepatitis B virus, hepatitis C virus and hepatitis D virus were tested in a consecutive sample of all patients referred for treatment of human immunodeficiency virus or acquired immunodeficiency syndrome. The variables sex, age, origin and exposure category were obtained from medical records and from the sexually transmitted diseases and acquired immunodeficiency syndrome surveillance database. Among 704 subjects, the prevalence of chronic hepatitis B carriage was 6.4% and past infection 40.2%. The presence of hepatitis B was associated with birth in hyperendemic areas of the Amazon basin, male sex and illegal drug use. The overall prevalence of hepatitis C was 5% and was associated with illegal drug use. The prevalence of hepatitis B and C among human immunodeficiency virus or acquired immunodeficiency syndrome patients in the Western Amazon basin was lower than seen elsewhere and is probably associated with the local epidemiology of these viruses and the degree of overlap of their shared risk factors. An opportunity presents itself to evaluate the prevention of hepatitis C through harm reduction policies and hepatitis B through vaccination programs among human immunodeficiency virus or acquired immunodeficiency syndrome patients.

Relevância:

80.00% 80.00%

Publicador:

Resumo:

As hepatites B e C continuam sendo um importante problema de saúde pública no Brasil. Neste estudo, determinou-se a prevalência de marcadores sorológicos para as hepatites B e C em indivíduos do Estado do Pará, atendidos no Laboratório Central de Saúde Pública do Pará, no período de janeiro de 2002 a dezembro de 2005. Foram realizados 11.282 exames para a pesquisa do HBsAg, 2.342 para o anti-HBc e 5.542 para o anti-vírus da hepatite C. A prevalência de HBsAg foi de 3,6% e predominou na faixa etária de 20 a 29 anos, enquanto que o anti-HBc foi observado em 37,7% dos indivíduos. A prevalência do antivírus da hepatite C foi de 3,6% e predominou entre indivíduos acima de 50 anos. Assim, as freqüências dos marcadores encontradas no Pará foram mais altas que em vários outros estados do país, sugerindo a necessidade de medidas de saúde publica mais eficazes no combate a estes agravos na região.

Relevância:

80.00% 80.00%

Publicador:

Resumo:

La Hepatitis C y B, junto al alcoholismo, continúan siendo un verdadero problema de Saludºblica. Sin embargo, actualmente no existen datos locales que nos permitan estimar la prevalencia de infección por virus hepatotropos en pacientes alcoholistas, sus genotipos, distrubución geográfica, ni su asociación con determinado tipo de alcoholismo. Además, la co-infección del virus de la inmunodeficiencia humana (VIH) con los virus de hepatitis supone un impacto muy importante desde el punto de vista sanitario y estadístico en nuestro país, ya que alrededor del 50 por ciento de los pacientes VIH positivos presentan dicha coinfección. Es así que, por ser de interés sanitario y por compartir­as de transmisión con el virus de hepatitis B y C, nos parece adecuado estudiar también la presencia de VIH-1 en esta población. Nuestro centro de atenciónºblica (IPAD), atiende a pacientes con trastornos por el consumo de sustancias; deshabitúa y rehabilita alcoholistas y a otros trastornos por consumo. Dichos pacientes, que viven en la ciudad capital, serán evaluados serológicamente para la detección de virus hepatotropos C-B y el VIH. Considerando que en nuestra institución se atiende a un 70 % de Alcoholistas Puros (con un promedio de 7 pacientes nuevos por día), nos resulta importante pesquisar la prevalencia de Virus C, B y VIH en nuestra población de alcoholistas. Toda esta problemática, es la propuesta de mi tesis doctoral. Hipótesis: estimamos encontrar en nuestra población de estudio cifras superiores a la prevalencia de estos virus publicada en bancos de sangre, lo cual se toma como referencia. Objetivos: -Conocer la prevalencia de infección por Virus de Hepatitis C, B y VIH-1 en pacientes alcoholistas de la ciudad de Córdoba, determinar si existe asociación de estos virus con algún tipo de alcoholismo, e identificar genotipos prevalentes y su distribución geográfica en Córdoba. Se incluirán en forma prospectiva y aleatorea, pacientes que concurren por primera vez, de ambos sexos, mayores de 21 años, alcoholistas puros (Gama-Delta-Epsilon de Jellinek). Se confeccionará una ficha, previo consentimiento informado, que permitirá categorizar al "tipo de bebedor". Se les realizará Serología para HCV, Ag HBs (en caso de reactividad se adicionará el Anti HBcore) y VIH. En caso de la positividad serológica, se procederá al frisado de los mismos, para la Genotipificación correspondiente. La recolección, captura y procesamiento de los datos se realizarán en una planilla o ficha. Luego se reubicarán en una base electrónica de datos y se harán los análisis estadísticos de los mismos. Resultados esperados: estimamos encontrar, coincidiendo con la bibliografía, un aumento en la prevalencia de estos virus. Creemos que pueden existir diferencias en los distintos tipos de alcoholismo debido a las diversas situaciones de riesgo a las que se exponen (más exposición en el Gama de Jellineck). Por esto esperamos encontrar un aumento en la prevalencia del Virus C, especialmente en el tipo consuetudinario (delta de Jellineck) por los trastornos nutritivos derivados del modo de consumo. Posiblemente esto pueda ser la llave de otros estudios que puedan esclarecer una vía de transmisión desconocida para este virus. De la misma manera, identificar los distintos genotipos existentes en nuestra ciudad y su distribución, y que como sabemos tiene implicancia en la evolución, y en los costos por el tiempo de tratamiento. Esta información será un aporte para programar medidas de vigilancia epidemiológica adecuada, elaborar estrategias preventivas además de aplicar el tratamiento correspondiente a los pacientes infectados que se detecten como tal durante el desarrollo del proyecto.